CCL2 and urinary bladder cancer: The invasive ability of bladder cancer cells is enhanced by upregulation of estrogen receptor β(ERβ) expression in both MCs and bladder cancer cells, resulting in increased signaling related to CCL2, CCR2, EMT, and MMP9 (156).